Pharmafile Logo

Unleashing Creativity in Virtual Pharma Engagements

Think outside the box with virtual engagements! Discover how creative asynchronous touchpoints can revolutionize your interactions. Explore everything from OLAs to treatment pathway profiling via a pharma-compliant virtual platform.

Explore the boundless potential of asynchronous touchpoints with our final tip in the series. Learn how creativity can redefine the scope and impact of your virtual interactions on the Impetus InSite Platform®.

10. Be Creative
Step beyond traditional advisory boards and team meetings. The Impetus InSite Platform® offers a versatile canvas for engaging participants in innovative ways. Whether it’s through Online Learning Activities (OLAs), journal clubs, case study discussions, post-(virtual) conference debriefs, patient journey mapping, or treatment pathway profiling, there’s a multitude of creative possibilities to explore. Embrace the flexibility of asynchronous touchpoints to craft unique and compelling engagement experiences that captivate and educate your participants.

This tip encourages you to think outside the box and discover new ways to leverage virtual tools for enhanced communication and deeper insight gathering.

For more creative strategies and insights into maximizing your virtual engagements, check out our blog: https://www.impetusdigital.com/2020/05/12/top-10-tips-for-optimizing-asynchronous-virtual-meetings/

Elevate your virtual engagements with Impetus Digital:

Stay connected for more creative ideas and updates:

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Virtual product launch planning: the ultimate playbook

We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...

Navigating the Nuances of Europe’s MedTech Industry

Richard Houlihan, CEO of EirMed, explores topics related to EUDAMED, the European Databank for Medical Devices, including the key pain points and concerns MedTech companies encounter related to EUDAMED and...

Pharma, Technology, and Healthcare in the New Normal

Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma conducts clinical trials and interacts with...

Traversing the Medtech Regulatory Landscape in the Interest of Patients

Dr. Bassil Akra, CEO of AKRA TEAM GmbH, takes a deep dive into the new approval process for medical devices in the EU and shares how his company is supporting...

Scanning for Health Indicators and Risks Through Your Smartphone

Vlado Bosanac, Co-Founder & Head of Strategy and Revenue Growth at Advanced Human Imaging, dives into the implications of increased integration of tech and data into daily life for the...

Virtual MSL/Sales training programs and events

Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events

Top 10 Benefits of Virtual Advisory Boards

As the world is slowly starting to open up again, it can be tempting to rush back to the pre-pandemic days of in-person advisory boards. However, it would be foolish...

Amplifying Opinions of Patients & Caregivers for Higher Quality of Care

Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey...